00
SUVENPHAR

Cohance Lifesciences Ltd.

430.80-11.5 (-2.61%)
8 Jul, 12:00 AM

Annual Reports and Financial Documents

Cohance Lifesciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Cohance Lifesciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018
  • Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Closure of Trading Window
  • Newspaper Publication26 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication
  • General24 Jun 2026
    Clarification On Volume Movement
    Clarification on Volume Movement
  • Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201119 Jun 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
  • Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201119 Jun 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201118 Jun 2026
    Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
    The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201118 Jun 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 201118 Jun 2026
    Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
  • Resignation of Director17 Jun 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    Resignation of Mr. Himanshu Agarwal as Executive Director and Chief Financial Officer of the Company
  • Postal Ballot14 Jun 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Postal Ballot Scrutinizer''s Report
  • Postal Ballot14 Jun 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Postal Ballot outcome and voting results
  • Analyst / Investor Meet2 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investors Meet
  • Reg.24(A)-Annual Secretarial Compliance30 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report
  • Analyst / Investor Meet25 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investors Meet
  • Newspaper Publication15 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication
  • Postal Ballot14 May 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Notice of Postal Ballot
  • Analyst / Investor Meet13 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Investors Meet
  • Newspaper Publication13 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication

Frequently Asked Questions

Where can I download the annual report of Cohance Lifesciences Ltd.?
Annual reports of Cohance Lifesciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Cohance Lifesciences Ltd.?
Quarterly earnings results and presentations of Cohance Lifesciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Cohance Lifesciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Cohance Lifesciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Cohance Lifesciences Ltd.?
Investor presentations and annual day presentations of Cohance Lifesciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Cohance Lifesciences Ltd.?
Corporate announcements and regulatory filings of Cohance Lifesciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Cohance Lifesciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Cohance Lifesciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Cohance Lifesciences Ltd.?
The ISIN (International Securities Identification Number) of Cohance Lifesciences Ltd. is INE03QK01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Cohance Lifesciences Ltd. listed?
Cohance Lifesciences Ltd. is listed on NSE and BSE. The NSE symbol is SUVENPHAR and the BSE code is -.
Where can I find the shareholding pattern of Cohance Lifesciences Ltd.?
The quarterly shareholding pattern of Cohance Lifesciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Cohance Lifesciences Ltd. on Sharpely?
Share price data for Cohance Lifesciences Ltd. is updated as of 8 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.